For instance, type I interferons like IFN-β have been shown to increase the tumor cytotoxicity of neutrophils; increase NET, ICAM1 and TNF-α expression; and polarize TANs toward an anti-tumor N1 phenotype in vivo [124]. Here, IFNB1 is linked to neoplasm.